CourseCourseQ BankQuestion BankDocsDocuments

C3.2.8—B-lymphocyte activation

B-lymphocyte activation explains how a specific barrier, pathogen interaction, immune mechanism or treatment response contributes to protection against infectious disease.

Syllabus
First assessment 2025
Objective
C3.2.8
Level
SL

Exam analysis

Chance of appearing1%of analysed past papers
Latest appearanceMay 2021
Most common paperPaper2
Typical marks6–7

Common command terms

  • Identify
  • Describe
  • Explain
  • Outline

Scoring notes

Common mistake
Confusing plasma cells, memory cells and helper T-cells in the activation sequence.

Recent exam appearances

May 2021Paper2 ["SL"] · TZ26(b)[ 7 ]C3.2.8—B-lymphocyte activation
May 2014Paper2 ["SL"] · TZ26(c)[ 6 ]C3.2.8—B-lymphocyte activation
Practice this objective

Coverage 2014–2021 · Updated 16 Jul 2026

B cells activate only after antigen-specific signals

An antigen-specific B lymphocyte is activated only after it interacts directly with its matching antigen and receives contact-dependent help from an activated helper T lymphocyte specific to the same antigen.

The two matching signals confirm antigen identity before the B cell divides. After activation, the B cell can produce antibody-secreting plasma cells and retained memory cells.

Specific antigen binds B-cell receptor → helper T cell activated by the same antigen contacts B cell → B cell activates → clonal expansion → plasma and memory cells.

A B cell recognizing one viral protein receives help only from a helper T cell activated by that same antigen type, preventing an unrelated B-cell clone from expanding.

Direct antigen binding alone is not sufficient in this model, and helper T-cell contact must be antigen-matched. Unactivated B cells do not yet secrete large antibody quantities.

B-lymphocyte activation

Assessment in practice

1–7 marks
How it is assessed

This objective is assessed through structured response, commonly using Identify / Describe / Explain.

Command terms

Identify / Describe / Explain / Outline

What earns marks

Mark schemes repeatedly reward named details, correct sequence and clear distinctions between similar processes.

Watch for

Confusing plasma cells, memory cells and helper T-cells in the activation sequence.

Representative question

Question 1

[Maximum number: 7]

Explain the production of antibodies when a patient is infected with the TB bacterium.

Defence Against Disease

  • Skin, mucus, cilia, lysozyme and clotting form primary barriers against pathogens.
  • Innate immunity is rapid and broad: phagocytes recognize, engulf and digest pathogens. Adaptive immunity is antigen-specific and forms memory.
  • Helper T-cells coordinate responses; activated B-cells undergo clonal selection, producing antibody-secreting plasma cells and memory cells. A second exposure therefore triggers a faster, stronger response.
  • HIV infects CD4 helper T-cells; their loss weakens immune coordination and can lead to AIDS.
  • Antibiotics target bacterial processes, not viruses. Antibiotic exposure selects resistant variants, which can spread by reproduction or plasmid transfer.
  • Vaccination creates active artificial immunity; high population immunity can indirectly protect susceptible people.
  • Evaluate disease and vaccine claims using reliable sources, trends, controlled comparisons, incidence and efficacy—not raw totals alone.

Concept essentials

  • B-lymphocyte activation has to be linked to the exact pathogen, cell, molecule or population process involved.
  • The biological effect of b-lymphocyte activation depends on the sequence from trigger to protective outcome.
  • Clear distinctions within b-lymphocyte activation prevent confusion with neighbouring immune responses.
  • Evidence for b-lymphocyte activation is strongest when mechanism and consequence are explained together.